HEADER IMMUNE SYSTEM 12-MAR-01 1I85 TITLE CRYSTAL STRUCTURE OF THE CTLA-4/B7-2 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: T LYMPHOCYTE ACTIVATION ANTIGEN CD86; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: IG V-TYPE (RECEPTOR BINDING) DOMAIN; COMPND 5 SYNONYM: B7-2; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4; COMPND 9 CHAIN: C, D; COMPND 10 FRAGMENT: EXTRACELLULAR DOMAIN; COMPND 11 SYNONYM: CTLA-4; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CD86; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET3A; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: CTLA4; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET3A KEYWDS IG V-TYPE DOMAIN, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.-C.D.SCHWARTZ,X.ZHANG,A.A.FEDOROV,S.G.NATHENSON,S.C.ALMO REVDAT 3 24-FEB-09 1I85 1 VERSN REVDAT 2 01-APR-03 1I85 1 JRNL REVDAT 1 04-APR-01 1I85 0 JRNL AUTH J.C.SCHWARTZ,X.ZHANG,A.A.FEDOROV,S.G.NATHENSON, JRNL AUTH 2 S.C.ALMO JRNL TITL STRUCTURAL BASIS FOR CO-STIMULATION BY THE HUMAN JRNL TITL 2 CTLA-4/B7-2 COMPLEX. JRNL REF NATURE V. 410 604 2001 JRNL REFN ISSN 0028-0836 JRNL PMID 11279501 JRNL DOI 10.1038/35069112 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.200 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 6516 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.300 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 606 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.31 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 56.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 415 REMARK 3 BIN R VALUE (WORKING SET) : 0.3720 REMARK 3 BIN FREE R VALUE : 0.4190 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 61 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3515 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM SIGMAA (A) : 0.69 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.52 REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.30 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.97 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1I85 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-MAR-01. REMARK 100 THE RCSB ID CODE IS RCSB013024. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X9B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9800 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7080 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 78.8 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.12100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 79.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.32100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG20K, HEPES, PH 7.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 27.28000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE CTLA-4 HOMODIMER IS GENERATED BY CHAIN D AND THE REMARK 300 TRANSLATONAL SYMMETRY MATE OF CHAIN C (APPLY THE OPERATOR X,Y,Z+ REMARK 300 1 TO CHAIN C) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B 0 REMARK 465 LYS C 1 REMARK 465 ALA C 2 REMARK 465 PRO C 121 REMARK 465 CYS C 122 REMARK 465 PRO C 123 REMARK 465 ASP C 124 REMARK 465 SER C 125 REMARK 465 ASP C 126 REMARK 465 LYS D 1 REMARK 465 ALA D 2 REMARK 465 SER D 27 REMARK 465 PRO D 28 REMARK 465 GLY D 29 REMARK 465 LYS D 30 REMARK 465 ALA D 42 REMARK 465 ASP D 43 REMARK 465 SER D 44 REMARK 465 PRO D 121 REMARK 465 CYS D 122 REMARK 465 PRO D 123 REMARK 465 ASP D 124 REMARK 465 SER D 125 REMARK 465 ASP D 126 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR C 112 OG1 CG2 REMARK 470 THR D 112 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O VAL D 116 N ASP D 118 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 1 91.52 167.41 REMARK 500 GLU A 9 -160.08 -101.47 REMARK 500 GLN A 16 -3.64 60.64 REMARK 500 ASN A 19 122.36 -24.86 REMARK 500 GLN A 21 42.86 -84.58 REMARK 500 ASN A 22 99.15 9.34 REMARK 500 LEU A 25 -0.89 -50.71 REMARK 500 GLU A 27 32.46 -95.61 REMARK 500 LEU A 40 -82.95 -86.73 REMARK 500 LEU A 45 31.97 25.96 REMARK 500 ARG A 60 46.55 -166.38 REMARK 500 SER A 62 113.31 -164.91 REMARK 500 SER A 65 -11.11 -48.06 REMARK 500 TRP A 68 -8.68 60.08 REMARK 500 THR A 69 -175.56 -62.40 REMARK 500 LYS A 80 94.56 -49.38 REMARK 500 LYS A 90 94.65 -59.56 REMARK 500 GLN B 16 -10.30 66.35 REMARK 500 PHE B 17 160.20 -49.64 REMARK 500 ALA B 18 65.52 -153.24 REMARK 500 ASN B 19 116.87 -17.29 REMARK 500 SER B 20 -61.34 -103.66 REMARK 500 GLN B 21 42.43 -80.79 REMARK 500 ASN B 22 100.62 12.54 REMARK 500 LEU B 25 3.22 -62.34 REMARK 500 ASP B 34 -160.14 -102.79 REMARK 500 LEU B 40 -81.66 -90.03 REMARK 500 LEU B 45 33.61 25.64 REMARK 500 ASP B 51 -37.55 -38.88 REMARK 500 ARG B 60 43.37 -153.89 REMARK 500 SER B 62 140.49 -172.40 REMARK 500 TRP B 68 11.65 51.47 REMARK 500 LEU B 70 103.32 -166.02 REMARK 500 ASN B 74 74.27 34.34 REMARK 500 LYS B 80 95.74 -55.88 REMARK 500 LYS B 90 85.40 -58.96 REMARK 500 GLN B 100 114.91 -162.03 REMARK 500 LYS C 30 139.75 173.96 REMARK 500 ALA C 31 131.41 -34.37 REMARK 500 ARG C 40 124.44 -177.68 REMARK 500 ALA C 42 -103.55 -91.02 REMARK 500 SER C 44 -12.59 -175.61 REMARK 500 MET C 55 -171.11 -63.54 REMARK 500 ASP C 64 -37.11 -35.34 REMARK 500 SER C 66 -144.76 -56.50 REMARK 500 SER C 73 84.69 -174.39 REMARK 500 ASN C 75 -23.84 60.61 REMARK 500 THR C 89 113.93 -22.83 REMARK 500 MET C 99 -153.75 -67.65 REMARK 500 TYR C 104 -168.75 -67.33 REMARK 500 TYR C 105 105.73 171.30 REMARK 500 ILE C 117 70.03 -36.96 REMARK 500 ASP C 118 81.91 179.81 REMARK 500 HIS D 4 107.61 -172.00 REMARK 500 THR D 32 -34.31 -150.70 REMARK 500 ARG D 40 118.87 -169.35 REMARK 500 MET D 55 -163.55 -68.55 REMARK 500 THR D 61 -68.17 -121.81 REMARK 500 PHE D 62 76.95 58.11 REMARK 500 LEU D 63 -105.85 41.40 REMARK 500 ASP D 64 -20.47 -176.28 REMARK 500 SER D 73 78.73 -167.26 REMARK 500 ASN D 75 -48.03 62.16 REMARK 500 THR D 89 130.26 -30.84 REMARK 500 MET D 99 -158.45 -64.05 REMARK 500 TYR D 104 -176.47 -67.25 REMARK 500 TYR D 105 123.50 177.74 REMARK 500 ILE D 117 76.03 -41.82 REMARK 500 ASP D 118 86.26 171.47 REMARK 500 REMARK 500 REMARK: NULL DBREF 1I85 A 1 109 UNP P42081 CD86_HUMAN 26 134 DBREF 1I85 B 1 109 UNP P42081 CD86_HUMAN 26 134 DBREF 1I85 C 1 126 UNP P16410 CTLA4_HUMAN 36 161 DBREF 1I85 D 1 126 UNP P16410 CTLA4_HUMAN 36 161 SEQADV 1I85 MET A 0 UNP P42081 INITIATING METHIONINE SEQADV 1I85 MET B 0 UNP P42081 INITIATING METHIONINE SEQADV 1I85 MET C 56 UNP P16410 THR 91 SEE REMARK 999 SEQADV 1I85 MET D 56 UNP P16410 THR 91 SEE REMARK 999 SEQRES 1 A 110 MET LEU LYS ILE GLN ALA TYR PHE ASN GLU THR ALA ASP SEQRES 2 A 110 LEU PRO CYS GLN PHE ALA ASN SER GLN ASN GLN SER LEU SEQRES 3 A 110 SER GLU LEU VAL VAL PHE TRP GLN ASP GLN GLU ASN LEU SEQRES 4 A 110 VAL LEU ASN GLU VAL TYR LEU GLY LYS GLU LYS PHE ASP SEQRES 5 A 110 SER VAL HIS SER LYS TYR MET GLY ARG THR SER PHE ASP SEQRES 6 A 110 SER ASP SER TRP THR LEU ARG LEU HIS ASN LEU GLN ILE SEQRES 7 A 110 LYS ASP LYS GLY LEU TYR GLN CYS ILE ILE HIS HIS LYS SEQRES 8 A 110 LYS PRO THR GLY MET ILE ARG ILE HIS GLN MET ASN SER SEQRES 9 A 110 GLU LEU SER VAL LEU ALA SEQRES 1 B 110 MET LEU LYS ILE GLN ALA TYR PHE ASN GLU THR ALA ASP SEQRES 2 B 110 LEU PRO CYS GLN PHE ALA ASN SER GLN ASN GLN SER LEU SEQRES 3 B 110 SER GLU LEU VAL VAL PHE TRP GLN ASP GLN GLU ASN LEU SEQRES 4 B 110 VAL LEU ASN GLU VAL TYR LEU GLY LYS GLU LYS PHE ASP SEQRES 5 B 110 SER VAL HIS SER LYS TYR MET GLY ARG THR SER PHE ASP SEQRES 6 B 110 SER ASP SER TRP THR LEU ARG LEU HIS ASN LEU GLN ILE SEQRES 7 B 110 LYS ASP LYS GLY LEU TYR GLN CYS ILE ILE HIS HIS LYS SEQRES 8 B 110 LYS PRO THR GLY MET ILE ARG ILE HIS GLN MET ASN SER SEQRES 9 B 110 GLU LEU SER VAL LEU ALA SEQRES 1 C 126 LYS ALA MET HIS VAL ALA GLN PRO ALA VAL VAL LEU ALA SEQRES 2 C 126 SER SER ARG GLY ILE ALA SER PHE VAL CYS GLU TYR ALA SEQRES 3 C 126 SER PRO GLY LYS ALA THR GLU VAL ARG VAL THR VAL LEU SEQRES 4 C 126 ARG GLN ALA ASP SER GLN VAL THR GLU VAL CYS ALA ALA SEQRES 5 C 126 THR TYR MET MET GLY ASN GLU LEU THR PHE LEU ASP ASP SEQRES 6 C 126 SER ILE CYS THR GLY THR SER SER GLY ASN GLN VAL ASN SEQRES 7 C 126 LEU THR ILE GLN GLY LEU ARG ALA MET ASP THR GLY LEU SEQRES 8 C 126 TYR ILE CYS LYS VAL GLU LEU MET TYR PRO PRO PRO TYR SEQRES 9 C 126 TYR LEU GLY ILE GLY ASN GLY THR GLN ILE TYR VAL ILE SEQRES 10 C 126 ASP PRO GLU PRO CYS PRO ASP SER ASP SEQRES 1 D 126 LYS ALA MET HIS VAL ALA GLN PRO ALA VAL VAL LEU ALA SEQRES 2 D 126 SER SER ARG GLY ILE ALA SER PHE VAL CYS GLU TYR ALA SEQRES 3 D 126 SER PRO GLY LYS ALA THR GLU VAL ARG VAL THR VAL LEU SEQRES 4 D 126 ARG GLN ALA ASP SER GLN VAL THR GLU VAL CYS ALA ALA SEQRES 5 D 126 THR TYR MET MET GLY ASN GLU LEU THR PHE LEU ASP ASP SEQRES 6 D 126 SER ILE CYS THR GLY THR SER SER GLY ASN GLN VAL ASN SEQRES 7 D 126 LEU THR ILE GLN GLY LEU ARG ALA MET ASP THR GLY LEU SEQRES 8 D 126 TYR ILE CYS LYS VAL GLU LEU MET TYR PRO PRO PRO TYR SEQRES 9 D 126 TYR LEU GLY ILE GLY ASN GLY THR GLN ILE TYR VAL ILE SEQRES 10 D 126 ASP PRO GLU PRO CYS PRO ASP SER ASP SHEET 1 A 5 LYS A 2 TYR A 6 0 SHEET 2 A 5 ARG A 97 LEU A 108 1 O GLU A 104 N ILE A 3 SHEET 3 A 5 LEU A 82 HIS A 88 -1 N TYR A 83 O SER A 103 SHEET 4 A 5 VAL A 29 GLN A 33 -1 O VAL A 29 N HIS A 88 SHEET 5 A 5 VAL A 39 VAL A 43 -1 N LEU A 40 O TRP A 32 SHEET 1 B 3 ALA A 11 LEU A 13 0 SHEET 2 B 3 LEU A 70 LEU A 72 -1 O LEU A 70 N LEU A 13 SHEET 3 B 3 THR A 61 PHE A 63 -1 O SER A 62 N ARG A 71 SHEET 1 C 6 LYS B 2 TYR B 6 0 SHEET 2 C 6 ARG B 97 LEU B 108 1 O GLU B 104 N ILE B 3 SHEET 3 C 6 LEU B 82 HIS B 88 -1 N TYR B 83 O SER B 103 SHEET 4 C 6 VAL B 29 GLN B 33 -1 O VAL B 29 N HIS B 88 SHEET 5 C 6 VAL B 39 TYR B 44 -1 N LEU B 40 O TRP B 32 SHEET 6 C 6 LYS B 47 GLU B 48 -1 N LYS B 47 O TYR B 44 SHEET 1 D 3 ALA B 11 ASP B 12 0 SHEET 2 D 3 LEU B 70 LEU B 72 -1 N LEU B 72 O ALA B 11 SHEET 3 D 3 THR B 61 PHE B 63 -1 N SER B 62 O ARG B 71 SHEET 1 E 4 VAL C 5 ALA C 6 0 SHEET 2 E 4 VAL C 22 TYR C 25 -1 N GLU C 24 O ALA C 6 SHEET 3 E 4 GLN C 76 ASN C 78 -1 N VAL C 77 O CYS C 23 SHEET 4 E 4 THR C 71 SER C 72 -1 O THR C 71 N ASN C 78 SHEET 1 F 3 VAL C 10 LEU C 12 0 SHEET 2 F 3 THR C 112 TYR C 115 1 O GLN C 113 N VAL C 11 SHEET 3 F 3 GLY C 90 TYR C 92 -1 O GLY C 90 N ILE C 114 SHEET 1 G 4 CYS C 50 TYR C 54 0 SHEET 2 G 4 VAL C 34 VAL C 38 -1 O VAL C 34 N TYR C 54 SHEET 3 G 4 CYS C 94 LEU C 98 -1 O LYS C 95 N THR C 37 SHEET 4 G 4 LEU C 106 GLY C 107 -1 O GLY C 107 N VAL C 96 SHEET 1 H 4 VAL D 5 ALA D 6 0 SHEET 2 H 4 VAL D 22 TYR D 25 -1 N GLU D 24 O ALA D 6 SHEET 3 H 4 GLN D 76 ASN D 78 -1 O VAL D 77 N CYS D 23 SHEET 4 H 4 THR D 71 SER D 72 -1 O THR D 71 N ASN D 78 SHEET 1 I 3 VAL D 10 LEU D 12 0 SHEET 2 I 3 THR D 112 TYR D 115 1 O GLN D 113 N VAL D 11 SHEET 3 I 3 GLY D 90 TYR D 92 -1 O GLY D 90 N ILE D 114 SHEET 1 J 4 CYS D 50 ALA D 51 0 SHEET 2 J 4 VAL D 34 VAL D 38 -1 N VAL D 38 O CYS D 50 SHEET 3 J 4 CYS D 94 LEU D 98 -1 N LYS D 95 O THR D 37 SHEET 4 J 4 LEU D 106 ILE D 108 -1 O GLY D 107 N VAL D 96 SSBOND 1 CYS A 15 CYS A 85 1555 1555 2.03 SSBOND 2 CYS B 15 CYS B 85 1555 1555 2.03 SSBOND 3 CYS C 23 CYS C 94 1555 1555 2.03 SSBOND 4 CYS C 50 CYS C 68 1555 1555 2.02 SSBOND 5 CYS D 23 CYS D 94 1555 1555 2.02 SSBOND 6 CYS D 50 CYS D 68 1555 1555 2.04 CISPEP 1 TYR C 100 PRO C 101 0 -0.55 CISPEP 2 PRO C 102 PRO C 103 0 0.20 CISPEP 3 TYR D 100 PRO D 101 0 -0.06 CISPEP 4 PRO D 102 PRO D 103 0 0.21 CRYST1 47.850 54.560 103.090 90.00 91.63 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020900 0.000000 0.000590 0.00000 SCALE2 0.000000 0.018330 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009700 0.00000